glp-1 blindness iLIV Clinic | π You've probably seen the headlines: βGLP1 medications can cause blindness!β But here's the fact β¬οΈ β A new JAMA study looked at 275 π Optometrists are warning GLP-1
Description
The FLOW trial demonstrated that semaglutide decreased kidney disease progression along with cardiovascular events in T2DM patients who had CKD while reducing HF events by 27% [58]
In the perioperative management of patients taking SGLT2 inhibitors, the optimal approach for preventing EDKA is to withhold the medication in any setting where predisposing factors for ketoacidosis are present (e.g

& Atkin, S

It does not raise blood sugar levels, making it a preferred choice for diabetics, GLP-1 users, and those on low-carb diets

States with the highest income burdens also have the highest obesity rates notably Mississippi, West Virginia, and Louisiana, where rates top 40%
